1256963-02-6 Usage
Uses
Used in Pharmaceutical Industry:
LEE011 is used as a CDK 4/6 inhibitor for the treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer. It is combined with an aromatase inhibitor for initial endocrine-based therapy, demonstrating statistically significant improvement in progression-free survival (PFS) compared to letrozole alone at the first pre-planned interim analysis.
References
S. Kim et al. "Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6- Reactivating Rb in cancer." Molecular Cancer Therapeutics 12.11_Supplement (2013):PR02-PR02.
Bardia, Aditya, et al. "Phase Ib/II study of LEE011, everolimus, and exemestane in postmenopausal women with ER+/HER2-metastatic breast cancer." Asco ?2014.
https://www.novartis.com/news/media-releases/novartis-kisqalir-ribociclib-lee011-receives-fda-approval-first-line-treatment
Check Digit Verification of cas no
The CAS Registry Mumber 1256963-02-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,6,9,6 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1256963-02:
(9*1)+(8*2)+(7*5)+(6*6)+(5*9)+(4*6)+(3*3)+(2*0)+(1*2)=176
176 % 10 = 6
So 1256963-02-6 is a valid CAS Registry Number.